EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Polypharmacy's Association With Mortality: Confounding From Underlying Morbidity

Emma Bjørk iD, Christopher T Rentsch iD, Rishi J Desai, Jacob H Andersen, Carina Lundby iD, Anton Pottegård

Journal of the American Geriatrics Society · 2025-08 · 73 (8) · 2485-2493

DOI: 10.1111/jgs.19572 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Geriatrics Society, online erschienen am 04.07.2025. Verfasst von Emma Bjørk und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Pharmacy Funen, Odense University Hospital, Odense, Denmark. Hauptthemen laut MEDLINE: Polypharmacy, Mortality. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Southern Denmark and the Danish Independent Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Studies consistently associate use of multiple medications with increased mortality. However, such studies often lack adequate adjustment for confounding, particularly from underlying diseases.

Objective

To illustrate challenges in studying the association between polypharmacy and mortality by examining this relationship in two separate populations.

Methods

A register‐based nationwide study utilizing a cohort of all Danish citizens admitted to nursing homes 2015–2021 ( n = 95,057) and a community dwelling population cohort aged ≥ 65 years ( n = 1,005,963). We examined the 1‐year mortality using a Kaplan Meier plot from date of nursing home admission or index date and modeled the association between the number of medications used and death using restricted cubic splines with varying levels of adjustment. Further, we modeled the association between the 20 most used drugs and 1‐year mortality.

Results

In the nursing home cohort, we found an approximately linear increase in mortality with the number of medications used. Adjusting for sex, age, and comorbidities markedly attenuated the association from an odds ratio of 4.70 (95% CI: 4.24–5.21) to 2.23 (95% CI: 1.99–2.49). Paradoxical associations were observed for individual drug classes, such as antidementia drugs showing a strong inverse association with mortality. When examining the stability of the number of drugs used over time, we found considerable fluctuations for individual residents. In the community dwelling population cohort, adjustment for covariates showed an even stronger impact on the association, reducing the odds ratio from 10.39 (95% CI: 9.79–11.03) to 1.34 (95% CI: 1.25–1.43). Further, the individual‐level use of medication was found to be stable over time in the general population.

Conclusion

The association between levels of polypharmacy and mortality is strongly affected by confounding by indication. Basic adjustment for comorbidities attenuates but does not fully eliminate the association, with residual association possibly driven by residual confounding. This emphasizes the need for cautious interpretation of findings associating high use of medication with mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolypharmacyMortalityHumansMaleFemaleAgedDenmarkAged, 80 and overNursing HomesIndependent LivingComorbidityRegistriesCohort Studies

Stichwörter der Autor:innen

drug therapymortalitynursing homepharmacoepidemiologypolypharmacy

Autor:innen und Institutionen

  • Hospital Pharmacy Funen, Odense University Hospital, Odense, Denmark.
  • Clinical Pharmacology, Pharmacy, and Environmental Medicine, Department of Public Health, University of Southern Denmark, Odense, Denmark.
  • Odense Deprescribing Initiative (ODIN), Odense University Hospital and University of Southern Denmark, Odense, Denmark.
  • Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
  • Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Emma Bjørk, Christopher T Rentsch, Carina Lundby

Förderung

  • University of Southern Denmark and the Danish Independent Research Council

Zitieren

APA

Bjørk, E., Rentsch, C. T., Desai, R. J., Andersen, J. H., Lundby, C., & Pottegård, A. (2025). Polypharmacy's Association With Mortality: Confounding From Underlying Morbidity. Journal of the American Geriatrics Society, 73(8), 2485-2493. https://doi.org/10.1111/jgs.19572

Vancouver

Bjørk E, Rentsch CT, Desai RJ, Andersen JH, Lundby C, Pottegård A. Polypharmacy's Association With Mortality: Confounding From Underlying Morbidity. Journal of the American Geriatrics Society. 2025;73(8):2485-2493. doi:10.1111/jgs.19572

BibTeX
@article{Bjrk2025,
  author = {Bjørk, Emma and Rentsch, Christopher T and Desai, Rishi J and Andersen, Jacob H and Lundby, Carina and Pottegård, Anton},
  title = {Polypharmacy's Association With Mortality: Confounding From Underlying Morbidity},
  journal = {Journal of the American Geriatrics Society},
  year = {2025},
  volume = {73},
  number = {8},
  pages = {2485--2493},
  doi = {10.1111/jgs.19572}
}
Kostenlos starten →